Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AUTODYN is a brand of autogenous (custom-made) veterinary vaccines developed and manufactured by Dyntec. These vaccines are produced using specific pathogenic microorganisms, primarily bacteria or viruses, that have been isolated from a particular farm or clinical case. Unlike commercial vaccines that contain standard strains, AUTODYN is tailored to the exact strains causing disease in a specific herd or flock, providing targeted immunological protection where standard products may be less effective. The product line includes various formulations such as **AUTODYN SOFT**, **AUTODYN inj** (for traditional injection), and **AUTODYN ID** (for intradermal administration). It is utilized across multiple animal species, including pigs, cattle, poultry, and rabbits, to prevent infections from pathogens like *Actinobacillus pleuropneumoniae*, *Streptococcus suis*, and *Escherichia coli*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AUTODYN.